UCB

UCB and Biogen’s dapirolizumab pegol paves path for systemic lupus erythematosus treatment

Read more

UCB and Biogen’s dapirolizumab pegol paves path for systemic lupus erythematosus treatment

Read more

EU approval boosts Bimzelx’s profile as innovative interleukin-17 inhibitor therapy: GlobalData

Read more

Lupin Appoints Johnny Mikell as Global Head of Quality

Read more

DRL to acquire select portfolio of UCB’s products business in India

Read more

Kezzler partners with Belgium-based UCB for Indian market

Read more